ClinicalTrials.Veeva

Menu

A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication

C

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Status

Completed

Conditions

Autoimmune Thyroid Disease
Congenital Hypothyroidism

Study type

Observational

Funder types

Other

Identifiers

NCT02307175
CIMS-2014-01

Details and patient eligibility

About

Prospective, open label single site study to demonstrate the safety and efficacy of Tc-99m pertechnetate produced by high energy cyclotron at CHUS.

Full description

The proposed clinical trial will be a prospective, case-controlled Phase I, open label, single site study. The first 10 consecutively enrolled patients will receive CYCLOTEC standard procedure thyroid imagery and an additional whole-body scans, and 20 subsequent case-matched controls, will receive GPERT and will also have additionnal whole body scan.

Enrollment

30 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Prescribed thyroid scan
  • Provided written informed consent prior to participation
  • Biochemical parameters within 5 times of the normal limits for age
  • WBC count > 3.0/μL
  • ANC count 1.5/μL
  • Platelets > 75,000/μL
  • Haemoglobin > 10 g/dL
  • Karnofsky Performance Scale score > 50

Exclusion criteria

  • Nursing or pregnant females
  • Biochemical parameters as measured outside 5 times the normal limits for age within 14 days of the scan
  • WBC < 3.0/μL
  • ANC < 1.5/μL
  • Platelets < 75,000/μL
  • Haemoglobin < 10 g/dL
  • Unable and unwilling to follow instructions and comply with the protocol
  • Unable or unwilling to provide written informed consent prior to participation in the study
  • Karnofsky Performance Scale score < 50

Trial design

30 participants in 2 patient groups

Cyclotec
Description:
The first 10 consecutively enrolled patients will have thyroid and whole body scan with CycloTec
generator produced Tc99m-pertechnetate
Description:
20 subsequent case-matched controls will have thyroid and whole body scan with conventional Tc99m-pertechnetate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems